The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.
The program’s faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research and computer science to accelerate the invention of life-saving medicines and the precision diagnostics needed to optimally treat individual patients. Our program brings together two approaches: Systems Pharmacology provides a powerful means to study the changes that promote disease and the ways in which therapeutic drugs function at a molecular level. Regulatory science focuses on the evaluation of drugs in clinical trials and on balancing the benefits and risks of new medicines.
Learn about our components:
Explore HiTS Research
News, Events, & Updates
Innovators in Therapeutics Speaker Series
Dr. David Altshuler, Executive VP, Global Research & CSO, Vertex Pharmaceuticals
March 24, 12:00pm ET
“New 3D Atlas of Colorectal Cancer Promises Improved Diagnosis, Treatment”
NIH Director’s Blog | January 31, 2023
2022 Global Conference on Regulatory Science Proceedings Available